Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

SARS-CoV-2 Positivity Rates Associated With Circulating 25-Hydroxyvitamin D Levels

SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels

Authors: Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF

Citation: PLoS One. 2020 Sep 17;15(9):e0239252. doi: 10.1371/journal.pone.0239252. eCollection 2020.

Specialties: Infectious Disease, COVID-19, Dermatology

Download key summary

Related content

On-Demand Webinar
The Association Between Vitamin D Levels and COVID-19 Positivity—and More
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Publication
Association of Changes in Lipid Levels with Changes in Vitamin D Levels in a Real-world Setting
Test FAQ
Vitamin D Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.